$357.33 0.4%
Price vs. AI Score (Last 150 days)
Data gathered: March 5

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

Data Bits

Data Bits Value / Change Benchmark
Job Posts 1,800 0%
Sentiment 62 0%
Webpage traffic 879,000 12.5%
Employee Rating 81 0%
Google Trends 50 8.7%
Patents 3,300 0%
4chan Mentions 0%
Facebook Engagement 747 -2.2%
Facebook followers 25,011 0%
Instagram Followers 26,016 0%
Reddit Mentions 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 3,598 0%
Twitter Mentions 37 94.7%
Youtube Subscribers 21,900 0%
News Mentions 0%
Customer reviews 0%
Lobbying Cost $53,000 N/A N/A
Business outlook 76 0%
Linkedin Employees 42,517 N/A
NPS 30 N/A

About Stryker

Stryker Corporation operates as a medical technology company. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Price $357.33
Target Price Sign up
Volume 31,330
Market Cap $134B
Year Range $253.17 - $357.33
Dividend Yield 0.91%
PE Ratio 42.71
Revenue per Employee $445,609
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '235.82B2.11B3.7B1.14B1.41B3.460
Q3 '234.91B1.75B3.16B692M1.1B2.460
Q2 '235B1.82B3.18B738M1.13B2.540
Q1 '234.78B1.76B3.02B592M896M2.140
Q4 '225.2B1.97B3.24B563M972M3.000

Insider Transactions View All

Boehnlein Glenn S filed to sell 20,194 shares at $342.8.
February 12 '24
STRYKER RONDA E filed to sell 3,665,032 shares at $342.
February 7 '24
STRYKER RONDA E filed to sell 3,664,032 shares at $343.5.
February 7 '24
STRYKER RONDA E filed to sell 3,662,832 shares at $344.5.
February 7 '24
STRYKER RONDA E filed to sell 3,665,598 shares at $341.2.
February 7 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Feb 5, 24 Buy $1K - $15K
Rohit Khanna
Feb 5, 24 Buy $1K - $15K
Rohit Khanna
Nov 8, 23 Buy $1K - $15K

What is the Market Cap of Stryker?

The Market Cap of Stryker is $134B.

What is Stryker's PE Ratio?

As of today, Stryker's PE (Price to Earnings) ratio is 42.71.

How Many People Work at Stryker?

As of our latest update, Stryker employed approximately 46,000 people worldwide. However, it's important to note that Stryker's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Stryker's revenue per employee?

$445,609. To calculate Stryker's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current price of Stryker?

Currently, the price of one share of Stryker is $357.33.

How can I analyze the SYK stock price chart for investment decisions?

The SYK stock price chart above provides a comprehensive visual representation of Stryker's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Stryker shares. Our platform offers an up-to-date SYK stock price chart, along with technical data analysis and alternative data insights.

Does SYK offer dividends to its shareholders?

Yes, Stryker (SYK) offers dividends to its shareholders, with a dividend yield of 0.91%. This dividend yield represents Stryker's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Stryker in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Stryker?

Some of the similar stocks of Stryker are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Becton Dickinson and Co.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.